Preliminary Results of a Retrospective Study on a Regimen Based on Orelabrutinib Combined with Anti-CD20 Monoclonal Antibody in Patients with Marginal Zone Lymphoma

被引：0
|
作者：
Peng, Hongling [1 ]
Xiang, Xixi [2 ]
Rao, Jun [2 ]
Yan, Wenzhe [1 ]
Cui, Yajuan [1 ]
Li, Ji [1 ]
Jiang, Yafeng [1 ]
Zhang, Xi [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp 2, Dept Hematol, Changsha, Peoples R China
[2] Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma & Chem Poisoning,Chongqing K, Chongqing, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6293 / 6293
页数：1
相关论文
共 50 条
  • [21] Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
    Singh, Sanjay Kumar
    Pokalwar, Santosh
    Bose, Sandip
    Gupta, Shivika
    Almal, Suhani
    Ranbhor, Ranjit Sudhakar
    BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 159 - 170
  • [22] Anti-CD20 antibodies for primary cutaneous B cell lymphoma. Preliminary results in dermatologic patients
    Gellrich, S
    Muche, JM
    Pelzer, K
    Audring, H
    Sterry, W
    HAUTARZT, 2001, 52 (03): : 205 - 210
  • [23] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    International Journal of Hematology, 2002, 76 : 411 - 419
  • [24] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [25] Successful treatment of refractory low grade duodenal lymphoma with rituximab, an anti-cd20 monoclonal antibody
    Ahmed, S
    Singh, A
    Krauss, J
    Wentz, T
    Gunaratnam, NT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 408 - 410
  • [26] Phase II study of acalabrutinib and an anti-CD20 monoclonal antibody in patients with anti-MAG mediated neuropathy
    Sarosiek, Shayna
    Doughty, Christopher T.
    Branagan, Andrew
    Flynn, Catherine A.
    Meid, Kirsten
    White, Timothy P.
    Little, Megan
    Leventoff, Carly
    Treon, Steven P.
    Castillo, Jorge J.
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Ofatumumab - Human anti-CD20 monoclonal antibody treatment of lymphoma/leukemia treatment of rheumatoid arthritis
    Wang, Y.
    Mealy, N.
    Bays, M.
    DRUGS OF THE FUTURE, 2007, 32 (05) : 408 - 410
  • [28] The Type II Glycoengineered Humanized Anti-CD20 Monoclonal Antibody MIL62 Combined with Lenalidomide in Chinese Patients with Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma: Results of a Multicenter, Single-Arm, Phase 1b/2 Trial
    Shi, Yuankai
    Qin, Yan
    Song, Yongping
    Zhou, Keshu
    Zhou, Hui
    Jing, Hongmei
    Xiang, Ying
    Wang, Zhao
    Wang, Zhen
    Zang, Aimin
    Bai, Ou
    Li, Zhenyu
    Zhang, Huilai
    BLOOD, 2021, 138
  • [29] In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
    Flavio Forrer
    Jianhua Chen
    Melpomeni Fani
    Pia Powell
    Andreas Lohri
    Jan Müller-Brand
    Gerhard Moldenhauer
    Helmut R. Maecke
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1443 - 1452
  • [30] In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study
    Forrer, Flavio
    Chen, Jianhua
    Fani, Melpomeni
    Powell, Pia
    Lohri, Andreas
    Mueller-Brand, Jan
    Moldenhauer, Gerhard
    Maecke, Helmut R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (09) : 1443 - 1452
12345